Fenofibrate Ameliorates Salt-Sensitive Hypertension by Improving Renal Metabolic Homeostasis
Clinical Science · 2026
DOI: 10.1042/cs20250379 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Science, 2026. Verfasst von Pengfei Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. Hauptthemen laut MEDLINE: Fenofibrate, Hypertension, Kidney, Hypolipidemic Agents. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Shaanxi Province Postdoctoral Science Foundation (Shaanxi Province Post-Doctoral Science Foundation), Basic Research Program of Shaanxi Provincial Natural Science Foundation.
Abstract (Originalsprache)
Salt-sensitive hypertension (SSH) presents a formidable clinical challenge, given its intricate pathophysiology and a scarcity of targeted treatment options. This study investigates the therapeutic potential and underlying mechanisms of fenofibrate, a peroxisome proliferator-activated receptor α (PPARα) activator, in SSH. Clinical observations indicate that SSH in male patients is often accompanied by dyslipidemia, with a positive correlation observed between blood pressure and lipid profiles—particularly triglycerides. In male Dahl salt-sensitive (SS) rats, a four-week oral administration of fenofibrate (100 mg/kg/day) prevented high-salt diet (HSD)-induced hypertension, dyslipidemia, and renal injury, without affecting body weight or food intake. Renal untargeted metabolomics demonstrated that HSD induced significant alterations in amino acid metabolism, the TCA cycle, pentose phosphate pathway, and arginine biosynthesis. Fenofibrate treatment reversed these metabolic abnormalities, notably restoring the levels of key amino acids such as arginine, serine, and branched-chain amino acids. Furthermore, fenofibrate stimulated the expression of renal PPARα and PPARγ. It potentiated nitric oxide (NO) synthesis by upregulating endothelial nitric oxide synthase (eNOS) protein expression and increasing arginine availability, improved the redox balance by enhancing antioxidant capacity, and elevated the cellular energy charge in the kidney. These findings demonstrate that fenofibrate ameliorates SSH by restoring renal metabolic homeostasis, enhancing NO synthesis, reducing oxidative stress, and improving bioenergetics, highlighting its promise as a therapeutic strategy for SSH, particularly in male patients with concurrent hyperlipidemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, China.
- College of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang, China.
ORCID-Profile: Pengfei Yang
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- Shaanxi Province Postdoctoral Science Foundation (Shaanxi Province Post-Doctoral Science Foundation)
- Basic Research Program of Shaanxi Provincial Natural Science Foundation
- Natural Science Foundation of Henan Province
- MOE | Fundamental Research Funds for the Central Universities (Fundamental Research Fund for the Central Universities)
- China Postdoctoral Science Foundation ()
- Youth Project of the Basic Research Program of Shaanxi Provincial Natural Science Foundation
Zitieren
APA
Yang, P., Liu, M., Li, Y., Zhou, L., Wu, L., Gao, D., Yang, Z., Zeng, L., Zheng, X., Mu, J., & Tian, Z. (2026). Fenofibrate Ameliorates Salt-Sensitive Hypertension by Improving Renal Metabolic Homeostasis. Clinical Science. https://doi.org/10.1042/cs20250379
Vancouver
Yang P, Liu M, Li Y, Zhou L, Wu L, Gao D, et al. Fenofibrate Ameliorates Salt-Sensitive Hypertension by Improving Renal Metabolic Homeostasis. Clinical Science. 2026. doi:10.1042/cs20250379
BibTeX
@article{Yang2026,
author = {Yang, Pengfei and Liu, Mingxiao and Li, Yuchen and Zhou, Luxin and Wu, Limei and Gao, Di and Yang, Zhe and Zeng, Li and Zheng, Xuewei and Mu, Jianjun and Tian, Zhongmin},
title = {Fenofibrate Ameliorates Salt-Sensitive Hypertension by Improving Renal Metabolic Homeostasis},
journal = {Clinical Science},
year = {2026},
doi = {10.1042/cs20250379}
}
EUVIMED